Interventions for preventing mastitis after childbirth
- PMID: 20687084
- DOI: 10.1002/14651858.CD007239.pub2
Interventions for preventing mastitis after childbirth
Update in
-
Interventions for preventing mastitis after childbirth.Cochrane Database Syst Rev. 2012 Oct 17;10:CD007239. doi: 10.1002/14651858.CD007239.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Sep 29;9:CD007239. doi: 10.1002/14651858.CD007239.pub4. PMID: 23076933 Updated.
Abstract
Background: Despite the health benefits of breastfeeding, initiation and duration rates continue to fall short of international guidelines. Many factors influence a woman's decision to wean; the main reason cited for weaning is associated with lactation complications, such as mastitis.
Objectives: To assess the effects of preventive strategies for mastitis and the subsequent effect on breastfeeding duration.
Search strategy: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (November 2009), CENTRAL (The Cochrane Library 2009, Issue 4), MEDLINE (1950 to November 2009), EMBASE (1974 to November 2009), CINAHL (1981 to November 2009), MIDIRS (1971 to November 2009), IPA (1970 to November 2009), AMED (1985 to November 2009) and LILACS (1982 to November 2009).
Selection criteria: We included randomised controlled trials of interventions for preventing mastitis in postpartum breastfeeding women.
Data collection and analysis: We independently identified relevant studies and assessed the trial quality. We contacted trial authors for missing data and information as appropriate.
Main results: We included five trials (involving 960 women). In three trials of 471 women, we found no significant differences in the incidence of mastitis between use of antibiotics and no antibiotics (risk ratio (RR) 0.43; 95% confidence interval (CI) 0.11 to 1.61; or in one trial of 99 women comparing two doses (RR 0.38; 95% CI 0.02 to 9.18). We found no significant differences for mastitis in three trials of specialist breastfeeding education with usual care (one trial); anti-secretory factor cereal (one trial); and mupirocin, fusidic acid ointment or breastfeeding advice (one trial).Generally we found no differences in any of the trials for breastfeeding initiation or duration; or symptoms of mastitis.
Authors' conclusions: There was insufficient evidence to show effectiveness of any of the interventions, including breastfeeding education, pharmacological treatments and alternative therapies, regarding the occurrence of mastitis or breastfeeding exclusivity and duration. While studies reported the incidence of mastitis, they all used different interventions. Caution needs to be applied when considering the findings of this review as the conclusion is based on studies, often with small sample sizes. An urgent need for further adequately powered research is needed into this area to conclusively determine the effectiveness of these interventions.
Comment in
-
Interventions for preventing mastitis after childbirth.Int J Evid Based Healthc. 2010 Dec;8(4):290. doi: 10.1111/j.1744-1609.2010.00192.x. Int J Evid Based Healthc. 2010. PMID: 21140990 No abstract available.
Similar articles
-
Interventions for preventing mastitis after childbirth.Cochrane Database Syst Rev. 2012 Oct 17;10:CD007239. doi: 10.1002/14651858.CD007239.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Sep 29;9:CD007239. doi: 10.1002/14651858.CD007239.pub4. PMID: 23076933 Updated.
-
Antenatal breastfeeding education for increasing breastfeeding duration.Cochrane Database Syst Rev. 2016 Dec 6;12(12):CD006425. doi: 10.1002/14651858.CD006425.pub4. Cochrane Database Syst Rev. 2016. PMID: 27922724 Free PMC article.
-
Treatments for breast engorgement during lactation.Cochrane Database Syst Rev. 2016 Jun 28;2016(6):CD006946. doi: 10.1002/14651858.CD006946.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Sep 18;9:CD006946. doi: 10.1002/14651858.CD006946.pub4. PMID: 27351423 Free PMC article. Updated.
-
Interventions for preventing mastitis after childbirth.Cochrane Database Syst Rev. 2020 Sep 29;9(9):CD007239. doi: 10.1002/14651858.CD007239.pub4. Cochrane Database Syst Rev. 2020. PMID: 32987448 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
Cited by
-
Incidence of and Risk Factors for Lactational Mastitis: A Systematic Review.J Hum Lact. 2020 Nov;36(4):673-686. doi: 10.1177/0890334420907898. Epub 2020 Apr 14. J Hum Lact. 2020. PMID: 32286139 Free PMC article.
-
Puerperal mastitis caused by limited community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clones.Front Med (Lausanne). 2024 Apr 19;11:1378207. doi: 10.3389/fmed.2024.1378207. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38707192 Free PMC article.
-
"Is our choice of empirical antibiotics appropriate for patients with methicillin resistant Staphylococcus aureus in breast abscess?".Iran J Microbiol. 2018 Dec;10(6):348-353. Iran J Microbiol. 2018. PMID: 30873261 Free PMC article.
-
The Frequency of Complications Associated with Breastfeeding in Breastfeeding Mothers.Med Arch. 2025;79(2):96-99. doi: 10.5455/medarh.2025.79.96-99. Med Arch. 2025. PMID: 40689277 Free PMC article.
-
Health professionals' advice for breastfeeding problems: not good enough!Int Breastfeed J. 2008 Sep 11;3:22. doi: 10.1186/1746-4358-3-22. Int Breastfeed J. 2008. PMID: 18786249 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical